AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc. (Nasdaq:MIRN), a clinical-stage biopharmaceutical company developing a broad pipeline of microRNA-based oncology therapeutics, today reported financial results and recent highlights for the three and nine months ended September 30, 2015.
Help employers find you! Check out all the jobs and post your resume.
